Preparation of biodegradable microcapsules of zidovudine using solvent evaporation: Effect of the modification of aqueous phase

International Journal of Pharmaceutics

Volumn 137, Issue 2, 1996, Pages 187-197

  Mandal, Tarun K ^a   Tenjarla, Srini ^b  

^a XAVIER UNIVERSITY OF LOUISIANA   (United States)

^b MERCER UNIVERSITY   (United States)

Author keywords

Biodegradable; Microcapsules; Poly(lactide glycolide); Solvent evaporation; Zidovudine

Indexed keywords

CALCIUM CHLORIDE; POLYGLACTIN; SOLVENT; ZIDOVUDINE;

ARTICLE; ENCAPSULATION; MICROCAPSULE; PARTICLE SIZE; PH; PRIORITY JOURNAL;

EID: 0030604693     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/0378-5173(96)04520-6     Document Type: Article

References (23)

1. Alonso, M.J., Cohen, S., Park, T.G., Gupta, R.K., Siber, G.R, and Langer, R., Determinants of release rate of tetanus vaccine from polyester microspheres. Pharm. Res., 10 (1993) 945-953.
2. Arshady, R., Microspheres and microcapsules, a survey of manufacturing techniques: part III: solvent evaporation. Polym. Eng. Sci., 30 (1990) 915-924.
3. Brook, I., Approval of zidovudine (AZT) for acquired immunodeficiency syndrome. J. Am. Med. Assoc., 258 (1987) 1517.
4. Chow. F-P.R. and Hamburger, A.W., In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS. Eur. J. Haematol., 47 (1991) 91-97.
5. Cleland, J.L. and Langer, R., Formulation and delivery of proteins and peptides: design and development strategies. In Cleland, J.L. and Langer, R. (Eds.), Formulation and Delivery of Proteins and Peptides, American Chemical Society, Washington, DC, 1994, pp. 1-19.
6. Colson, E.R., Horwitz, R.I., Bia, F.J. and Viscoli, CM., Zidovudine (AZT) for the treatment of patients infected with human immunodeficiency virus type 1. An evaluation of effectiveness in clinical practice. Arch. Intern. Med., 151 (1991) 709-713.
7. Devita, V.T., Broder, S., Fauci, A.S., Kovacs, J.A. and Chabner, B.A., Developmental therapeutics and the acquired immunodeficiency syndrome. Ann. Inter. Med., 106 (1987) 568-581.
8. Douglas, R.D., Antimicrobial agents. In Gilman, A.G., Rall, T.W., Nies, A.S. and Taylor, P. (Eds.), The pharmacological basis of therapeutics, Pergaman press, New York, 1990, pp. 1182-1184.
9. Fischl, M.A., Richman, D.D., Hansen, N., Collier, A.C., Carey, J.T., Para, M.F., Hardy, W.D., Powderly, W.G., Allan, J.D., Wong, B., Merigan, T.C., Dolin, R., McAuliffe, V.J., Hyslop, N.B., Rhame, F.S., Balfour, H.H., Spector, S.A., Volberding, P., Pettinelli, C, Anderson, J. and the AIDS Clinincal Trials Group, The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. Ann. Inter. Med., 112 (1990) 727-737.
10. Klecker, R., Collins, J., Yarchoan, R., Thomas, R., Jenkins, J.F., Broder, S. and Myers, C.E., Plasma and cerebrospinal fluid pharmacokinetics of 3-azido-3-deoxythymidine: a novel pyrimidine analog with potential application for the treatment of patients with AIDS and related diseases. Clin. Pharmacol. Ther., 41 (1987) 407-412.
11. Lewis, D.H., Biodegradable polymers as drug delivery systems. In Chasin, M. and Langer, R. (Eds.), Drugs and Pharmaceutical Sciences. Vol. 45., Marcel Dekker, New York, 1990, pp. 1-42.
12. Lutton, J.D., Mathew, A., Levere, R.D. and Abraham, N.G., Role of heme metabolism in AZT-induced bone marrow toxicity. Am. J. Hematol., 35 (1990) 1-5.
13. Mac, A., Negi, D. and Friend, D. Preparation and characterization of poly (styrene) microcapsules containing corrosion inhibitors. J. Microencapsulation., 6 (1989) 361-367.
14. Mandal, T.K. and Tenjarla, S., Biodegradable microcapsules: Optimization of formulation using factorial design. Pharm. Sci., 1 (1995) 367-370.
15. Mandal, T.K., Lopez-Anaya, A., Onyebueke, E. and Shekleton, M., Preparation of biodegradable microcapsules containing zidovudine (AZT) using solvent evaporation technique. J. Microencapsulation, (1996a) in press.
16. Mandal, T.K., Shekleton, M., Onyebueke, E., Washington, L. and Penson, T., Effect of formulation and processing factors on the characteristics of biodegradable microcapsules of zidovudine. J. Microencapsulation, (1996b) in press.
17. Ogawa, Y., Yamamoto, M., Takada, S., Okada, H. and Shimamoto, T., Controlled release of leuprolide acetate from polylactic acid or copoly (lactic/glycotic) acid microcapsules: influence of molecular weight and copolymer ratio of polymer. Chem. Pharm. Bull., 36 (1988) 1502-1507.
18. Pitt, C.G., Cha, Y., Shah, S.S. and Zhu, K.J., Blends of PVA and PGLA: control of the permeability and degrability of hydrogels by blending. J. Control. Rel., 19 (1992) 189-200.
19. Richman, D.D., Fischl, M.A., Grieco, M.H., Gottliab, M.S., Volberding, P.A., Laskin, O.L., Leedom, J.M., Groopman, J.E., Mildvan, D., Hirsch, M.S., Jackson, G.G., Durack, D.T., Nusinoff-Lehrman, S. and the AZT Collaborative Working Group, The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. N. Engl. J. Med., 317 (1987) 192-197.
20. Schugens, Ch., Laruelle, N., Nihant, N., Grandfils, Ch., Jerome, R. and Teyssie, Ph., Effect of emulsion stability on the morphology and porosity of semicrystalline poly 1-lactide microparticles prepared by w/o/w double emulsion-evaporation. J. Control. Rel, 32 (1994) 161-176.
21. Shargel, L. and Yu, A.B.C., Applied Biopharmaceutics and Pharmacokinetics, 3rd Edn, Appleton and Lange, Connecticut, 1993, pp. 232-233.
22. Song, C.X., Sun, H.F. and Feng, X.D., Microspheres of biodegradable block copolymer for long-acting controlled delivery of contraceptives. Polymer J., 19 (1987) 485-491.
23. Yan, C., Resau, J.H., Hewetson, J., West, M., Rill, W.L. and Kende, M., Characterization and morphological analysis of protein-loaded poly(lactide-co-glycolide) microparticles prepared by water-in-oil-water emulsion technique. J. Control. Rel., 32 (1994) 231-241.